HUB1 is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia
Authors
Itoh, M
Watanabe, M
Yamada, Y
Furukawa, K
Taniguchi, M
Hata, T
Schmitt, M
Ikeda, H
Yamaguchi, M
Ohno, T
Nakashima, K
Shiku, H
Citation
M. Itoh et al., HUB1 is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia, INT J ONCOL, 14(4), 1999, pp. 703-708
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF ONCOLOGY
SICI code
1019-6439(199904)14:4<703:HIAAFE>2.0.ZU;2-R
Abstract
The immunological screening of a cDNA phage expression library prepared fro
m an adult T cell leukemia (ATL) cell line, ST1, was performed with IgG cla
ss antibodies in the serum of an ATL patient by the SEREX method to analyze
the repertoire of antigen molecules in ATL. Ten different cDNAs, 7 previou
sly reported and 3 newly identified, were isolated. One of the identified c
DNAs was homologous to the recently reported gene, HTLV-I USRE binding prot
ein 1 (HUB 1) encoding a protein binding to a possible repressor element of
the long terminal repeat of the human T lymphotropic virus type I (HTLV-I)
. The obtained cDNA was expressed as a fusion protein with glutathione S-tr
ansferase. HUB1 protein was prepared by subsequent treatment of the fusion
protein with thrombin. Reactivity of IgG serum samples from ATL patients, a
symptomatic HTLV-I carriers and normal donors against the purified protein
was examined by Western blot analysis. Twenty-one out of 30 samples (70.0%)
from ATL patients, 10/24 samples (41.7%) from HTLV-I carriers and 9/24 sam
ples (37.5%) from healthy donors showed positive reactivity, indicating the
autoantigenicity of HUB1. The development of ATL may be related to higher
production of antibodies against HUB1.